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Introduction: 
The association of  myelodysplastic syndrome 
(MDS) and extracapillary glomerulonephritis 
(ECGN) is exceptional. Only a few cases of  
this association have previously been described. 
All described cases are related to anti-neutrophil 
cytoplasmic antibodies [1,2]. It is not certain 
that the two pathologies are linked and their 
association can seem random. However, some 
common pathophysiological points may suggest 
the existence of  a probable link between these 
entities. 
Reported case: 
We report a case of  a 52-year-old man, who 
was followed for 20 years for MDS with 
involvement of  the three bloodlines and 
monosomy 7, receiving symptomatic treatment 
(low transfusion requirements, granulocyte 
colony-stimulating factor) without any specific 
treatment. This patient was hospitalised in 
an intensive care unit for severe sepsis due to 
pulmonary infection with acute renal failure. 
Empirical antibiotic therapy was established 
with a favourable course of  the infection. 
The persistence of  renal failure led to patient 
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Introduction: The association of  myelodysplastic syndrome and extracapillary glomerulonephritis is 
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admission in our department. The initial 
assessment showed renal insufficiency (creatinine 
at 5.2 mg/dL), proteinuria at 0.6 g/day and 
microscopic haematuria. A histological study of  
renal biopsy identified an extracapillary cellular 
and fibro-cellular proliferation (six glomeruli 
among 11) without tubulo-interstitial or vascular 
lesion (Figure 1 and 2). In immunofluorescence, 
the biopsy showed mesangial deposits of  IgM 
without other specific deposits. Electronic 
microscopy was not performed. Antineutrophil 
cytoplasmic antibodies were negative. The rest 
of  the laboratory tests commonly applied to 
rapidly progressive glomerulonephritis (anti-
DNA, anti-glomerular basement membrane, 
fractions C3 and C4 complement, viral serologies 
((hepatitis B and C, HIV)) and cryoglobulinemia) 
showed no significant abnormalities. The 
patient subsequently received daily bolus of  
methyl-prednisolone (500 mg per day) relayed 
by oral prednisone (1mg/kg/per day) for three 
days. The outcome was favourable, with a rapid 
and significant improvement of  renal function. 
Corticosteroid was rapidly reduced and then 
stopped after seven weeks (creatinine at 1.3 mg/
dL after two months). After one year of  follow 
up, serum creatinine was 1.5 mg/dL.
Discussion: 
MDS are a heterogeneous group of  disorders 
characterised by impairment of  clonal 
haematopoietic stem cells and leading to a 
morphologically abnormal and ineffective 
haematopoiesis (bone marrow failure) for 
one or more of  the three blood cell lines [3]. 
The ineffective haematopoiesis is partly due to 
increased apoptosis of  bone marrow precursors. 
Patients with MDS often develop sepsis. Bacterial 
infections are the commonest cause [4]. Patients 
with monosomy 7 and partial deletions of  long 
arm of  chromosome 7 have been demonstrated 
to have impaired neutrophil function [5]. 
Various glomerular nephropathies associated 
with MDS have been reported in literature on the 
subject (table) [1,2,6-10].
In the specific case of  post-infectious ECGN, 
it appears that genetic factors are necessary for 
the induction of  the disease. Thus, during an 
epidemic of  a ‘nephritogenic’ germ, only a few 
patients present with glomerulonephritis, and 
clinical presentation will differ from one patient to 
another. Real defects in the glomerular basement 
membrane were observed during ECGN. 
These gaps would be secondary to the action of  
proteolytic enzymes and oxygen radicals released 
by leukocytes in contact with the glomerular 
endothelium. These leukocytes are activated 
by various factors [11] which are the main pro-
inflammatory cytokines, particularly IL-1 and 
TNF-α [12]. 
Several studies show that chromosomal and gene 
abnormalities might contribute to dysplastic and 
apoptotic phenotype of  MDS by inhibiting cell 
survival signals and/or increased pro-apoptotic 
signals. Other publications have reported 
elevated levels of  TNF-α and IL-2 in MDS 
[13,14]. TNF-α secreted by undifferentiated bone 
marrow mononuclear cells is identified as a key 
cytokine in the genesis of  apoptosis in MDS [15]. 
The pathophysiological mechanism involved in 
the genesis of  glomerular nephropathy in patients 
with MDS is still unclear. A pathogenic role has 
been attributed to immune dysregulation [16]. 
TNF-α is increased in both ECGN and MDS, but it 
could be a late consequence of  the immunological 
cascade that leads to the appearance of  ECGN. 
The hypothesis of  a common genetic 
predisposition is evoked because of  the presence 
of  a genetic predisposition during ECGN and 
the existence of  a great diversity of  genetic 
abnormalities in MDS.
The diagnosis of  MDS and glomerulopathy was 
simultaneous in most described cases [1,2,6,8]. In 
some of  these cases the etiopathogenic treatment 
of  one entity leads to the curing of  another [2,6]. 
In the case of  our patient, ECGN has occurred 
after a long evolution of  an MDS complicated by 
a late severe infection.
Conclusion: 
It remains unclear why MDS may be associated 
with other glomerulopathies such as extra 
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capillary glomerulonephritis (ECGN). However, 
renal impairment must be looked for in MDS.
References:
1. Komatsuda A. Crescentic glomerulonephritis 
accompanied by myeloperoxidase anti-neutrophil 
cytoplasmic antibodies in a patient suffering from 
myelodysplastic syndrome with trisomy 7. Am J 
Kidney Dis 1998; 31: p. 336-340.
2.  Morschhauser F. Glomerular injury in chronic 
myelomonocytic leukemia. Leuk-Lymphoma 1995; 
18: p. 479-483.
3.  Heaney M.L. Myelodysplasia. New England 
Journal of  Medicine 1999; 340: p. 1649-1660.
4.  Pomeroy C., Oken M.M., Rydell R.E., et al. 
Infection in the myelodysplastic syndromes. Am J 
Med 1991; 90: p. 338-44.
5.  Ruutu P., Ruutu T., Repo H., et al. Defective 
neutrophil migration in monosomy 7. Blood 1981; 
58: p. 39-45.
6.  Paydas S. A case with membranous glomerulonephritis 
and myelodysplastic syndrome. Nephron 1992; 62: 
p. 231-232.
7.  Enright H. Paraneoplastic autoimmune phenomena 
in patients with myelodysplastic syndromes: Response 
to immunosuppressive therapy. British Journal of  
Haematology 1995; 91: p. 403-408.
8.  Doukkali O. Glomérulonéphrite extra-membraneuse 
et syndrome myélodysplasique. Néphrologie 2004; 
25 (2): p. 59-61.
9.  Saitoh T. Myelodysplastic syndromes with nephrotic 
syndrome. American Journal of  Haematology 
1999; 60: p. 200-204.
10. Hayashi S. A case of  myelodysplastic syndrome 
associated with IgA nephropathy. Nippon Ronen 
Igakkai Zasshi 1999; 36: p. 373-376.
11. Bonsib S.M. Glomerular basement membrane 
discontinuities: Scanning electron microscopic study 
of  acellular glomeruli. American Journal of  
Pathololgy 1985; 119: p. 357-360.
12. Atkins R.C. Modulators of  crescentic 
glomerulonephritis. Journal of  the American 
Society of  Nephrology 1996; 11: p. 2271-8.
13. Kitagawa M. Overexpression of  tumour necrosis 
factor (TNF)-alpha and interferon (IFN)-gamma by 
bone marrow cells from patients with myelodysplastic.
syndromes. Leukaemia 1997; 11: p. 2049-2054.
14. Zombos N. Increased levels of  soluble interleukin-2 
receptors and tumour necrosis factor in serum of  
patients with myelodysplastic syndromes. Blood 
1991; 77: p. 413-414.
15. Raza A. Novel insights into the biology of  
myelodysplastic syndromes: Excessive apoptosis and 
the role of  cytokines. Int J Haematol 1996; 63: p. 
265-278.
16. Bogdanovi R. Glomerular involvement in 
myelodysplastic syndromes. Pediatric Nephrology 
2001; 16: p. 1053-1057
Hamzi M.A. et al. Myelodysplastic Syndrome and Extracapillary Glomerulonephritis
20 African Journal of Nephrology (2012) 15 (1): 18-21
Photos 1 and 2: Renal biopsy examined by light microscopy (Periodic acid-Schiff  (1) and reticulin (2) stains): 
circumferential epithelial Croissants.
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Résumé:
Introduction: L’association d’un syndrome myélodysplasique (SMD) et d’une glomérulonéphrite extra-
capillaire est exceptionnelle. Seuls deux cas ont été décrits jusqu’à présent. 
Observation: Il s’agit d’un patient de 52 ans, avec un antécédent de syndrome myélodysplasique, qui a 
développé un syndrome de glomérulonéphrite rapidement progressive. La biopsie rénale a objectivé une 
glomérulonéphrite extra-capillaire. 
Discussion: L’association d’un syndrome myélodysplasique à une glomérulopathie est exceptionnelle et 
souvent considérée comme fortuite. Seuls quelques cas sont décrits dans la littérature. Une relation entre 
les deux pathologies est possible. Le lien de causalité entre ces deux affections demeure inconnu.
Conclusion: la notion selon laquelle le syndrome myélodysplasique peut s’accompagner de néphropathies 
glomérulaires diverses implique de rechercher une atteinte rénale au cours de cette affection hématologique.
